Home › MRA Applauds Latest Melanoma Drug Approval
 

Keywords :   


MRA Applauds Latest Melanoma Drug Approval

2014-12-29 01:14:14| drugdiscoveryonline Home Page

The Melanoma Research Alliance (MRA) recently welcomed news that the U.S. Food & Drug Administration (FDA) has granted approval to Bristol Myers-Squibb’s new immunotherapy drug, Opdivo (nivolumab), for the treatment of metastatic melanoma

Tags: latest drug approval melanoma

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Ex-cabinet secretary says 200,000 job is underpaid
06.10Hurricane Leslie Graphics
06.10Hurricane Leslie Forecast Discussion Number 16
06.10Hurricane Leslie Wind Speed Probabilities Number 16
06.10Hurricane Leslie Forecast Advisory Number 16
06.10Hurricane Leslie Public Advisory Number 16
06.10Summary for Hurricane Leslie (AT3/AL132024)
06.10Hurricane Kirk Graphics
More »